Our Mission

We envision a world in which there is free and unrestricted access to information on malaria, independent of geographical locality or socio-economic status. No matter who you are, where you are, or what you do, access to information is the key to knowledge.
 
Knowledge empowers. Empowered people prevent and control malaria better.

____________________________________________________________

 

Last week at MalariaWorld... Forum discussions

This week I see that Rune Bosselmann responded to the forum topic posted by Mark Birchmore regarding the definition of long-lasting IRS. These forums serve to engage MalariaWorld members in contemporary issues in malaria and its control. Although at times we see good engagement, we encourage subscribers to vent their thoughts and ideas more broadly. Mark launched his own forum topic, and so can you. If there is anything you would like to discuss in public, don't hesitate to start a topic. And in case you need help, just contact us (info@malariaworld.org).
 
Serves us right to thank Remco Suer who has taken care of the newsletter during our summer break. Besides our Nairobi office of course, without whom we would not be able to sustain our service during the holidays.
 
Enjoy this week's MalariaWorld - The MW team.

International Conference: Parasite to prevention - Advances in the understanding of malaria


Date: 20-22 October 2010
Venue: Edinburgh Conference Centre Heriot-Watt University, Edinburgh UK
 
This international conference brings together leading researchers and industry representatives who will review important recent findings in parasite and vector biology, disease pathophysiology and immunology, disease treatment, prevention and control. Attendees will learn about the latest developments in key areas and initiatives that are at the forefront of malaria research. To visit the conference site click here

4.666665
Average: 4.7 (3 votes)

MalariaWorld proud to announce partnership with Elsevier

It has taken quite a few meetings, but today we are proud to announce our partnership with Elsevier Publishers. Together we have established a new malaria portal called Malaria Nexus, which you can access here.
 
MalariaWorld subscribers will receive additional benefits, as Malaria Nexus will feature an article database from which full pdf papers can be extracted free of charge.
 
MalariaWorld members will also receive discounts on Elsevier books.
 
More details will follow soon (by direct email to you and in our weekly newsletter).
 
The MW team.

A Comparison of Methods to Detect and Quantify the Markers of Antimalarial Drug Resistance

Author(s): 
Ian M. Hastings, Christian Nsanzabana, and Tom A. Smith
Reference: 
Am. J. Trop. Med. Hyg., 83(3), 2010, pp. 489-495
Contact email: 
hastings@liverpool.ac.uk

Simple counting dramatically reduced sample size and estimate precision, and we show that analysis of unambiguous samples is biased, leaving maximum likelihood or similar statistical inference as the only practical option.

Open Access | Scaling Up Malaria Control in Zambia: Progress and Impact 2005–2008

Author(s): 
Elizabeth C., John M., et al.
Reference: 
Am. J. Trop. Med. Hyg., 83(3), 2010, pp. 480-488
Contact email: 
elizabethchizema@yahoo.co.uk

Zambia national survey, administrative, health facility, and special study data were used to assess progress and impact in national malaria control between 2000 and 2008.

Mutations in the Antifolate-Resistance-Associated Genes Dihydrofolate Reductase and Dihydropteroate Synthase in Plasmodium vivax Isolates from Malaria-Endemic Countries

Author(s): 
Feng L., Chae S., et al.
Reference: 
Am. J. Trop. Med. Hyg., 83(3), 2010, pp. 474-479
Contact email: 
lufeng981@hotmail.com

We sequenced the Plasmodium vivax dihydrofolate reductase (pvdhfr) and dihydropteroate synthase (pvdhps) genes to examine the prevalence and extent of point mutations in isolates from malaria-endemic countries.

Open Access | Malaria Incidence and Prevalence Among Children Living in a Peri-Urban Area on the Coast of Benin, West Africa: A Longitudinal Study

Author(s): 
Alain N., Annette E., et al.
Reference: 
Am J Trop Med Hyg 2010 83: 465-473
Contact email: 
nahum_alain@yahoo.fr

Three cross-sectional surveys were also carried out. Malaria incidence showed a marked seasonal distribution with two peaks: the first corresponding to the long rainy season, and the second corresponding to the overflowing of Lake Nokoue.

Evaluation of Recurrent Parasitemia after Artemether-Lumefantrine Treatment for Uncomplicated Malaria in Children in Western Kenya

Author(s): 
Joseph V. Woodring, Bernhards Ogutu, David Schnabel, John N. Waitumbi, Cara H. Olsen, Douglas S. Walsh, D. Gray Heppner, Jr.,and Mark E. Polhemus
Reference: 
Am. J. Trop. Med. Hyg., 83(3), 2010, pp. 458-464
Contact email: 
joseph.woodring@us.army.mil

Although recrudescence in some cannot be ruled out, our cohort had a shorter median time to RP compared with other artemether-lumefantrine treatment studies.

Open Access | Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

Author(s): 
Jamie T. Griffin, T. Deirdre Hollingsworth, Azra C. Ghani, et al
Reference: 
PLoS Med 7(8): e1000324
Contact email: 
a.ghani@imperial.ac.uk

Interventions using current tools can result in major reductions in P. falciparum malaria transmission and the associated disease burden in Africa. Reduction to the 1% parasite prevalence threshold is possible in low- to moderate-transmission settings when vectors are primarily endophilic (indoor-resting), provided a comprehensive and sustained intervention program is achieved through roll-out of interventions.

Open Access | Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

Author(s): 
Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM
Reference: 
Malaria Journal 2010, 9:249 (1 September 2010)
Contact email: 
cmanyando@yahoo.com

These data suggest that exposure to AL in pregnancy, including first trimester, is not associated with particular safety risks in terms of perinatal mortality, malformations, or developmental impairment. However, more data are required on AL use during the first trimester.

Syndicate content